GE Healthcare, Geron Expand Deal for Stem Cell-based Assays
October 08, 2012
GE Healthcare, Geron Expand Deal for Stem Cell-based Assays
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- GE Healthcare, Geron Partner on Stem Cell-Based Assays
June 30, 2009 / GenomeWeb Daily News - Ambry and GE Offering Illumina TruSight Tumor Panel for Research, Planning to Validate for Clinical Use
April 17, 2013 / Clinical Sequencing News - New Products: Illumina's TruSight Tumor Content; Ambry's Tumor Profiling Services; More
April 10, 2013 / Clinical Sequencing News - Progenitor Cell Therapy to Evaluate Sistemic Technology
March 14, 2013 / Gene Silencing News - Austrian Lab Accredited for NGS-based HLA Testing
February 28, 2013 / GenomeWeb Daily News